| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ab8466bce065232b391d77292152f21f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84d9adaa7e7ce01ce8020f5c721aba10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23C9-152
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23C9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 |
| filingDate |
1996-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f376744ce2d9ed7b6f560b6dc8ac8bf6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_722febcfe631d95a84e4ffdfccd45a6a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7c4969e2eef510fc2b9c53f9efd67f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3dea16214a5bdb39357a8fcbfeb6e79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0674cead80ab32824e31959cca4c32e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f2225d25f9757f061be931a72f70101
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aaf57ab2f365abd0d04f6c6d87e7f780
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_070c7cdfd46e0c19c4e858c515bdab6a |
| publicationDate |
1997-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2234664-A1 |
| titleOfInvention |
A method for inhibiting attachment of h. influenzae to human cells using phosphorylated recombinant human beta-casein |
| abstract |
A method is provided for inhibiting the attachment of H. influenzae to human cells, such as pharyngeal cells, by contacting the bacilli with phosphorylated recombinant human .beta.-casein that have at least 3 phosphate groups. A product containing phosphorylated recombinant human .beta.-casein may be a liquid enteral nutritional product such as infant formula. The enteral nutritional product may be used for the prevention and treatment of otitis media in infants. The phosphorylated recombinant human .beta.-casein may also be administered as a throat spray or used in nose drops or a spray. |
| priorityDate |
1995-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |